Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Catalent, Inc.

CTLTNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$63.48
$0.00(0.00%)
U.S. Market opens in 17h 26m

Catalent, Inc. (CTLT) Stock Overview

Explore Catalent, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.5B
P/E Ratio-11.02
EPS (TTM)$-2.28
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1.74

CTLT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Catalent, Inc. (CTLT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.02 and a market capitalization of 11.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
5.31%
6-Month Change
9.73%
Year-to-Date (YTD) Change
N/A
1-Year Change
28.45%
3-Year Change
-38.92%
5-Year Change
3.27%
All-Time (Max) Change
217.56%

Contact Information

732 537 6200
14 Schoolhouse Road, Somerset, NJ, 08873

Company Facts

170,000 Employees
IPO DateJul 31, 2014
CountryUS

Frequently Asked Questions